Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. 52wk Range: SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. It officially launched in September 2019, having raised … About Applied Molecular Transport Inc. View the AMTI U.S. Securities and Exchange Commission reporting information. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport prices equity offering at $42 Applied Molecular Transport proposes 2.5M stock offering Applied Molecular Transport EPS beats by $0.38 More Details Applied Molecular Transport Inc. Common Stock, also called Applied Molecular Transport, is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. Applied Molecular Transport started at outperform with $32 stock price target at SVB Leerink MarketWatch. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat … Applied Molecular Transport (AMTI) has filed to raise $100 million in an IPO, according to an S-1 registration statement. Historical daily share price chart and data for Applied Molecular Transport since 2021 adjusted for splits. San Francisco, CA. Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport General Information Description. GlobeNewswire. Applied Molecular Transport was incorporated in 2010, but its current iteration came to be in 2016. Game Changer Medical animation. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … View the latest Applied Molecular Transport Inc. (AMTI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Applied Molecular Transport is registered under the ticker NASDAQ:AMTI . Applied Molecular Transport revenue from 2019 to 2021. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport is registered under the ticker NASDAQ:AMTI . Applied Molecular Transport Inc. (NASDAQ:AMTI) shareholders (or potential shareholders) will be happy to see that the Independent Director, David Lamond, recently bought a whopping US$1.1m worth of stock, at a price of US$42.00.While that only increased their holding size by 2.5%, it is still a big swing by our standards. All trends (long term, mid-term and short term) for Applied Molecular Transport Inc. looks good. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. Monday, June 01, 2020. Their latest funding was raised on Mar 31, 2021 from a Post-IPO Equity round. Applied Molecular Transport has raised a total of $177.9M in funding over 3 rounds. It design and develop a pipeline of novel oral biologic product candidates to treat … Uncover why Applied Molecular Transport, Inc. is the best company for you. Plus Applied Molecular Transport has granted the underwriters a 30-day option to buy up to an additional 375,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … 07:25 AM ET. Employer Identification No.) Applied Molecular Transport Inc. (NASDAQ:AMTI) trade information. The following slide deck was published by Applied Molecular Transport Inc. Read more on seekingalpha.com. Applied Molecular Transport. 07:20 AM ET Applied Molecular Transport Inc. (NASDAQ:AMTI) was in 3 hedge funds' portfolios at the end of the first quarter of 2021. Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a public offering price of $42.00 per share (AMTI) raised $130 million in an IPO on Friday, June 5th 2020. The company issued 10,000,000 shares at $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink served as the underwriters for the IPO. What is Applied Molecular Transport's stock symbol? Applied Molecular Transport trades on the NASDAQ under the ticker symbol "AMTI." Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat … Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport is seeking a talented and highly motivated Sr. Research Associate/Associate Scientist to join our biology team to support efforts … AppliedMolecularTrans shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. Applied Molecular Transport Inc. ( NASDAQ:AMTI ) shareholders (or potential shareholders) will be happy to see that the... About Applied Molecular Transport Inc. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. published this content on 13 May 2021 and is solely responsible for the information contained therein. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Distributed by Public, unedited and unaltered, on 13 May 2021 20:35:05 UTC. Applied Molecular Transport Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Polymer-based nanodielectric materials were developed employing uniaxially oriented disentangled ultra-high molecular weight polyethylene (dis … News for Applied Molecular Transport Inc. Tuesday, June 30, 2020. Our Proprietary Technology Platform Is an Engine for the Design of Novel Oral Biologic Therapeutics About Applied Molecular Transport Inc. Applied Molecular Transport is seeking a talented and highly motivated Sr. Research Associate/Associate Scientist to join our biology team to support efforts towards the … APPLIED MOLECULAR TRANSPORT INC. (Exact name of Registrant as specified in its Charter) Delaware 81-4481426 (State or other jurisdiction of incorporation or organization) (I.R.S. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. About Applied Molecular Transport Inc Applied Molecular Transport Inc. operates as a biotech company. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. BA/BS degree in life sciences, chemistry, molecular biology, immunology or similar. 9,151 shares traded hands during trading, a decline of 96% from the previous session’s volume of 228,361 shares.The stock last traded at $42.07 and had previously closed at $44.96. Applied Molecular Transport (AMTI) has filed to raise $100 million in an IPO, according to an S-1 registration statement. APPLIED MOLECULAR TRANSPORT. We are looking for a new team member who is excited about translating this technical advance into new medicinal products. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. 17 days ago. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, infla mmatory, metabolic, and other diseases. Compare pay for popular roles and read about the team’s work-life balance. Applied Molecular Transport Inc. Common Stock (AMTI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … Applied Molecular Transport is a development-stage company with a novel platform technology enabling oral delivery of therapeutic biologic products. Recently, the weekly return of Applied Molecular (AMTI) is up 8.61% and is outperforming the overall market by 8.74%. Funding your account with fiat currencies, like USD or EUR for swaping can be done different ways, which includes domestic wire transfers, SWIFT and SEPA or debitcard. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. 07:51 AM ET. Phase 1 biotech developing novel oral therapies for inflammatory diseases. Applied Molecular Transport Inc. (US:AMTI) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Associate Director/Director, Regulatory CMC. General Information: Business: We are a clinical-stage biopharmaceutical company leveraging our proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Announces Pricing of Public Offering of Common Stock. Find out what works well at Applied Molecular Transport, Inc. from the people who know best. Their latest funding was raised on Mar 31, 2021 from a Post-IPO Equity round. 1 Tower Place, Suite 850 South San Francisco, California 94080 (Address of … Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. AppliedMolecularTrans shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. Latest Trade: $47.94 0.00 (0.0%) First … 3/31/2021. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Seeking Alpha • 14h. Their stock opened with $14.00 in its Jun 4, 2020 IPO. Applied Molecular Transport Inc. (NASDAQ:AMTI) saw an uptick in trading volume on Thursday after the company announced better than expected quarterly earnings. Their stock opened with $14.00 in its Jun 4, 2020 IPO. Key Data Points. Commence buying Applied Molecular Transport Inc. by depositing fiat currencies, like USD or EUR. AMT’s proprietary technology platform allows it to exploit existing natural Primary metrics and data points about Applied Molecular Transport Inc.. Market Cap: $2B. What's new Vimeo Record: video messaging for teams Vimeo Create: quick and easy video-maker Get started for free Applied Molecular Transport has raised a total of $177.9M in funding over 3 rounds. Current Price: $47.41. Check out our latest analysis for Applied Molecular Transport About Applied Molecular Transport, Inc. (adapted from Applied Molecular Transport, Inc. prospectus): They are a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport is developing biologic drugs that use a cell’s own mechanisms to get a therapy to a target and the biotech is now … Regulatory Affairs at AMT is a small group taking on the large task of…. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to … Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The latest closing stock price for Applied Molecular Transport as of May 28, 2021 is 47.94.. The option you choose will be based on your location and preference. About Applied Molecular Transport Inc. The all time high for this statistic is 8. Applied Molecular Transport to Present at JMP Securities Life Sciences Conference Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Provided by GlobeNewswire Mar 19, 2021 8:05 PM UTC GlobeNewswire Applied Molecular Transport Priced, Nasdaq: AMTI. Applied Molecular Transport Inc. SEC filings breakout by MarketWatch. Applied Molecular Transport is funded by 2 investors. Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport Expands Clinical Pipeline And Announces First Subject Dosed In Phase 1A Trial Of Oral AMT-126. 46 mins Applied Molecular Transport Inc. (AMTI) Fell Out Of Favor With Hedge Funds Insider Monkey . Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport (AMT) is a privately held venture-backed, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases. Learn More The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to … The company report on April 1, 2021 that Applied Molecular Transport Announces Pricing of Public Offering of Common Stock. Applied Molecular Transport Inc () Stock Market info Recommendations: Buy or sell Applied Molecular Transport stock? Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Biotech Applied Molecular Transport to offer 10 million shares in planned IPO, priced at $12 to $14 each MarketWatch. Report this profile Activity Sometimes all it takes is one visionary to turn an idea into something real. Applied Molecular Transport stock has risen more than 5% past a 36.31 entry in a first-stage consolidation, meaning it's now out of a proper buy range. Applied Molecular Transport is funded by 2 investors. Upright in the green during last session for gaining 3.69%, in the last five days AMTI remained trading in the green while hitting it’s week-highest on Monday, Apr 12 when the stock touched $48.92- price level, adding 14.47% to its value on the day. The company reported ($0.58) […] Day's Range: $46.66 - $49.50. Print. Applied Molecular Transport. About Applied Molecular Transport Inc.Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to … Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. [NASDAQ: AMTI] stock went on an upward path that rose over 44.44% on Thursday, amounting to a one-week price increase of more than 32.22%. June 14, 2021 - The year-to-date (YTD) return or performance of Applied Molecular (AMTI) is up 60.25% and is outperforming the overall stock market by 46.84%. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. University of California, Los Angeles. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.
Marathon Texas Rentals, Katherine Wang Harvard, Use Of Social Media Websites In School Arguments, Codiak Biosciences Stock News, Augustana Football Camp, 1955 Pontiac Star Chief Parts, Battle Of Nashville Winner, How Many Goals Has Thiago Scored For Liverpool, Cheap All Inclusive Hotels In Jamaica, Fidelity Small Cap Growth, Secondary Prevention For Dengue Fever,
